Accepted Articles                   Back to the articles list | Back to browse issues page

XML Print


1- Department of Occupational Therapy, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2- Department of Basic Sciences, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3- Department of Neurology, Iran University of Medical Sciences, Hazrat Rasool Hospital, Tehran, Iran
Abstract:  
Introduction: There is a need to have appropriate information about the ability of Parkinsonchr('39')s disease (PD) patients to perform cognitive instrumental activities of daily living (IADL). The purpose of the present study was to assess the psychometric properties of the Persian version of the Penn Parkinsonchr('39')s Daily Activities Questionnaire-15 (PDAQ-15).
Methods: A total of 165 knowledgeable informants of PD patients completed the PDAQ-15. The Clinical Dementia Rating Scale, Hoehn and Yahr staging, Hospital Anxiety and Depression Scale (HADS) and Lawton IADL scale were included in the study. Internal consistency and test-retest reliability were evaluated by Cronbachchr('39')s alpha coefficient and intraclass correlation coefficient (ICC), respectively. To examine the dimensionality of the questionnaire, exploratory factor analysis was used. The construct validity was assessed using Spearman rank correlation test. To assess the discriminative validity, PDAQ-15 scores were compared across cognitive stages.
Results: The PDAQ-15 showed strong internal consistency (Cronbachchr('39')s α = 0.99) and test-retest reliability (ICC= 0.99). Only one dimension identified for the PDAQ-15 in the factor analysis. There was strong correlation between PDAQ-15 with depression domain of HADS scale and Lawton IADL scale. (rs = |0.71–0.95|). The correlation of PDAQ-15 with anxiety domain of HADS scale was moderate (rs = 0.66). Discriminative validity analysis showed that the PDAQ-15 has significant power to discriminate between PD patients across cognitive stages.
Conclusion: These results suggest that the PDAQ-15 is a valid and reliable PD-specific instrument that can be useful in clinical and research settings.
Type of Study: Original | Subject: Cognitive Neuroscience
Received: 2020/02/17 | Accepted: 2020/06/16

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2020 All Rights Reserved | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb